To determine if ZNF143 expression contributes to tumor malignancy, such as recurrence and metastasis in breast cancer patients, we compared disease-free survival between selected patients with altered ZNF143 expression and the remaining patients in the whole data set (Figure 6A,B). Here, ZNF143 is linked to breast carcinoma.